Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Narcissus tazetta bulb extract is a botanical extract derived from the bulbs of the Bunch-flowered Daffodil. It contains natural growth inhibitors known as "dormins," which are substances produced by plants to maintain dormancy and protect against environmental stress. When applied topically, this extract is designed to capture the plant's dormant state to slow down human cell proliferation, specifically targeting the hair follicle matrix. By inhibiting the proliferation of keratinocytes and inducing the transition of the hair follicle from the anagen (growth) phase to the telogen (resting) phase, it effectively reduces hair shaft elongation and delays hair regrowth. It is primarily investigated for cosmetic applications and the treatment of dermatological conditions such as hirsutism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on narcissus tazetta bulb extract.